These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4830142)

  • 1. Development of specific cell-dependent antibody during growth of a syngeneic rat sarcoma.
    Basham C; Currie GA
    Br J Cancer; 1974 Mar; 29(3):189-98. PubMed ID: 4830142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of cell-dependent antibody (CDA) and inhibitory antibody by protein-A affinity chromatography and the effect of fractions on antibody-dependent cellular cytotoxicity (ADCC).
    Sato N; Yabuki Y; Toh K; Ishii Y; Kikuchi K
    Immunology; 1979 Mar; 36(3):421-6. PubMed ID: 437836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 4. The presence of tumour-specific membrane antigen in the serum of rats with chemically induced sarcomata.
    Thomson DM; Steele K; Alexander P
    Br J Cancer; 1973 Jan; 27(1):27-34. PubMed ID: 4568460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers.
    Thomson DM; Sellens V; Eccles S; Alexander P
    Br J Cancer; 1973 Nov; 28(5):377-88. PubMed ID: 4758368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma.
    Price MR; Baldwin RW
    Int J Cancer; 1977 Aug; 20(2):284-91. PubMed ID: 197028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of tumour growth on the evolution of cytotoxic lymphoid cells in rats bearing a spontaneously metastasizing syngeneic fibrosarcoma.
    Currie GA; Gage JO
    Br J Cancer; 1973 Aug; 28(2):136-46. PubMed ID: 4730177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of serum factors modulating splenic cytotoxicity in a syngeneic rat tumour system.
    Chalmers PJ; Matthews N; Nairn RC
    Br J Cancer; 1976 Dec; 34(6):645-50. PubMed ID: 1087566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of cyclophosphamide on in vitro correlates of tumor immunity.
    Steele G; Sjögren HO; Ankerst J
    Int J Cancer; 1974 Dec; 14(6):743-52. PubMed ID: 4377004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system.
    Matthews N; Chalmers PJ; Flannery GR; Nairn RC
    Br J Cancer; 1976 Mar; 33(3):279-89. PubMed ID: 773397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Br J Cancer; 1977 Jun; 35(6):834-43. PubMed ID: 194618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to a syngeneic rat tumour: evolution of serum cytotoxicity and blockade.
    Flannery GR; Chalmers PJ; Rolland JM; Nairn RC
    Br J Cancer; 1973 Oct; 28(4):293-8. PubMed ID: 4202457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro demonstration of in situ autologous tumour-cell cytotoxicity in MSV-induced tumours in A/SN mice.
    Becker S; Haskill S
    Br J Cancer; 1981 Mar; 43(3):284-93. PubMed ID: 7053211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody production by spleen cells of mice bearing MCA-induced tumours: search for suppressor cells.
    Yagello M; Lespinats G; Fridman WH
    Int J Cancer; 1978 Aug; 22(2):136-41. PubMed ID: 359487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of SV40 tumor-mediated suppression of spleen cell cytotoxicity by antibody.
    Prather SO; Lausch RN
    J Immunol; 1977 Jan; 118(1):203-10. PubMed ID: 187698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of syngeneic complement for revealing antibody-induced cytotoxicity against a rat hepatoma.
    Price MR; Höffken K; Baldwin RW
    Transplantation; 1979 Aug; 28(2):140-3. PubMed ID: 483360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of surgical removal of a rat sarcoma on lymphocyte cytotoxicity.
    Rogers GW; Miller EE; Rosato FE; Rosato EF
    J Surg Oncol; 1977; 9(3):307-11. PubMed ID: 875396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-reacting embryonic antigen in the membrane of rat sarcoma cells which is immunogenic in the syngeneic host.
    Thomson DM; Alexander P
    Br J Cancer; 1973 Jan; 27(1):35-47. PubMed ID: 4631228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
    Tamerius JD; Hellström I
    J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.